Word

NUPHASE

Status

Registered

Status Code

700

Status Date

Tuesday, April 9, 2024

Serial Number

97552581

Registration Number

7350459

Registration Date

Tuesday, April 9, 2024

Mark Type

4000

Filing Date

Wednesday, August 17, 2022

Published for Opposition

Tuesday, October 17, 2023

Trademark Owner History

Beijing NuPhase Therapeutics Co., Ltd. - Owner At Publication

Classifications

5 Diagnostic preparations for medical purposes; medicines for the treatment of cancer, immune diseases, diseases affecting the central nervous system, and rare diseases; medicinal drinks; biochemical medicines for the treatment of cancer, immune diseases, diseases affecting the central nervous system, and rare diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer, immune diseases, diseases affecting the central nervous system, and rare diseases; pharmaceutical preparations for the treatment of cancer, immune diseases, diseases affecting the central nervous system, and rare diseases; biological tissue cultures for medical purposes; biological preparations for the treatment of cancer, immune diseases, diseases affecting the central nervous system, and rare diseases; reagent paper for medical purposes; nutraceutical preparations for therapeutic purposes or the treatment of cancer, immune diseases, diseases affecting the central nervous system, and rare diseases

Trademark Events

Apr 9, 2024

Registered-Principal Register

Apr 9, 2024

Notice Of Registration Confirmation Emailed

Mar 1, 2024

1(B) Basis Deleted; Proceed To Registration

Jan 9, 2024

Notice Of Allowance Cancelled

Mar 1, 2024

Case Assigned To Intent To Use Paralegal

Jan 9, 2024

Teas Delete 1(B) Basis Received

Dec 12, 2023

Noa E-Mailed - Sou Required From Applicant

Oct 17, 2023

Official Gazette Publication Confirmation E-Mailed

Oct 17, 2023

Published For Opposition

Sep 27, 2023

Notification Of Notice Of Publication E-Mailed

Sep 13, 2023

Approved For Pub - Principal Register

Sep 7, 2023

Teas/Email Correspondence Entered

Sep 7, 2023

Correspondence Received In Law Office

Sep 5, 2023

Teas Response To Office Action Received

Jun 6, 2023

Notification Of Non-Final Action E-Mailed

Jun 6, 2023

Non-Final Action E-Mailed

Jun 6, 2023

Non-Final Action Written

Jun 5, 2023

Assigned To Examiner

Oct 7, 2022

Preliminary/Voluntary Amendment - Entered

Oct 7, 2022

Assigned To Lie

Aug 27, 2022

Teas Voluntary Amendment Received

Sep 7, 2022

New Application Office Supplied Data Entered

Aug 20, 2022

New Application Entered